Cargando…

Right Compared With Left Thoracic Approach Esophagectomy for Patients With Middle Esophageal Squamous Cell Carcinoma

Background: In China, open surgical approaches for esophageal cancer (EC) can be divided into two techniques, the right- and left- transthoracic esophagectomy. Although there is an increasing number of instances that use the right side, the optimal surgical technique remains unclear. Based in a larg...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yan, Li, Yin, Liu, Xianben, Zhang, Ruixiang, Sun, Haibo, Xing, Wenqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649421/
https://www.ncbi.nlm.nih.gov/pubmed/33194596
http://dx.doi.org/10.3389/fonc.2020.536842
_version_ 1783607323910995968
author Zheng, Yan
Li, Yin
Liu, Xianben
Zhang, Ruixiang
Sun, Haibo
Xing, Wenqun
author_facet Zheng, Yan
Li, Yin
Liu, Xianben
Zhang, Ruixiang
Sun, Haibo
Xing, Wenqun
author_sort Zheng, Yan
collection PubMed
description Background: In China, open surgical approaches for esophageal cancer (EC) can be divided into two techniques, the right- and left- transthoracic esophagectomy. Although there is an increasing number of instances that use the right side, the optimal surgical technique remains unclear. Based in a large cancer center with rich experience of both transthoracic side approaches, this study compared the long-term survival of patients treated by these two surgical techniques. Methods: The patients included in this study underwent a right transthoracic esophagectomy (Right, McKeown) or left transthoracic esophagectomy (Left, Sweet, or chest neck dual-incision) for esophageal squamous cell carcinoma (ESCC) between January 2015 and October 2018. The overall survival(OS) rate and perioperative data between the two groups were then retrospectively analyzed. Results: We included 437 patients who underwent Right (n = 202) and Left (n = 235) approaches for ESCC. There was a significantly longer median operative time (250 vs. 190 min, P < 0.001) and longer median postoperative hospital stay (17 vs. 14 days, P < 0.001) in the Right side group. The OS at 5-years was 49.9% in the Right group and 52.45% in the Left group; hazard ratio (HR) (95% CI): 1.002 (0.752–1.337), p = 0.987. Conclusions: For middle thoracic ESCC without suspected lymph node metastasis in the upper mediastinum, the esophagectomy through the Left thoracic approach could achieve the same OS as the Right side, with better short-term outcomes.
format Online
Article
Text
id pubmed-7649421
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76494212020-11-13 Right Compared With Left Thoracic Approach Esophagectomy for Patients With Middle Esophageal Squamous Cell Carcinoma Zheng, Yan Li, Yin Liu, Xianben Zhang, Ruixiang Sun, Haibo Xing, Wenqun Front Oncol Oncology Background: In China, open surgical approaches for esophageal cancer (EC) can be divided into two techniques, the right- and left- transthoracic esophagectomy. Although there is an increasing number of instances that use the right side, the optimal surgical technique remains unclear. Based in a large cancer center with rich experience of both transthoracic side approaches, this study compared the long-term survival of patients treated by these two surgical techniques. Methods: The patients included in this study underwent a right transthoracic esophagectomy (Right, McKeown) or left transthoracic esophagectomy (Left, Sweet, or chest neck dual-incision) for esophageal squamous cell carcinoma (ESCC) between January 2015 and October 2018. The overall survival(OS) rate and perioperative data between the two groups were then retrospectively analyzed. Results: We included 437 patients who underwent Right (n = 202) and Left (n = 235) approaches for ESCC. There was a significantly longer median operative time (250 vs. 190 min, P < 0.001) and longer median postoperative hospital stay (17 vs. 14 days, P < 0.001) in the Right side group. The OS at 5-years was 49.9% in the Right group and 52.45% in the Left group; hazard ratio (HR) (95% CI): 1.002 (0.752–1.337), p = 0.987. Conclusions: For middle thoracic ESCC without suspected lymph node metastasis in the upper mediastinum, the esophagectomy through the Left thoracic approach could achieve the same OS as the Right side, with better short-term outcomes. Frontiers Media S.A. 2020-10-26 /pmc/articles/PMC7649421/ /pubmed/33194596 http://dx.doi.org/10.3389/fonc.2020.536842 Text en Copyright © 2020 Zheng, Li, Liu, Zhang, Sun and Xing. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zheng, Yan
Li, Yin
Liu, Xianben
Zhang, Ruixiang
Sun, Haibo
Xing, Wenqun
Right Compared With Left Thoracic Approach Esophagectomy for Patients With Middle Esophageal Squamous Cell Carcinoma
title Right Compared With Left Thoracic Approach Esophagectomy for Patients With Middle Esophageal Squamous Cell Carcinoma
title_full Right Compared With Left Thoracic Approach Esophagectomy for Patients With Middle Esophageal Squamous Cell Carcinoma
title_fullStr Right Compared With Left Thoracic Approach Esophagectomy for Patients With Middle Esophageal Squamous Cell Carcinoma
title_full_unstemmed Right Compared With Left Thoracic Approach Esophagectomy for Patients With Middle Esophageal Squamous Cell Carcinoma
title_short Right Compared With Left Thoracic Approach Esophagectomy for Patients With Middle Esophageal Squamous Cell Carcinoma
title_sort right compared with left thoracic approach esophagectomy for patients with middle esophageal squamous cell carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649421/
https://www.ncbi.nlm.nih.gov/pubmed/33194596
http://dx.doi.org/10.3389/fonc.2020.536842
work_keys_str_mv AT zhengyan rightcomparedwithleftthoracicapproachesophagectomyforpatientswithmiddleesophagealsquamouscellcarcinoma
AT liyin rightcomparedwithleftthoracicapproachesophagectomyforpatientswithmiddleesophagealsquamouscellcarcinoma
AT liuxianben rightcomparedwithleftthoracicapproachesophagectomyforpatientswithmiddleesophagealsquamouscellcarcinoma
AT zhangruixiang rightcomparedwithleftthoracicapproachesophagectomyforpatientswithmiddleesophagealsquamouscellcarcinoma
AT sunhaibo rightcomparedwithleftthoracicapproachesophagectomyforpatientswithmiddleesophagealsquamouscellcarcinoma
AT xingwenqun rightcomparedwithleftthoracicapproachesophagectomyforpatientswithmiddleesophagealsquamouscellcarcinoma